Who We Are

Onegene Biotechnology develops transformative therapeutics for the chronic and complex diseases. Our UniStac platform allows rationale-based design of multispecific drug in true plug-and-play manner.

Key Milestones
  • 01


  • 09

    Seed Fund closed

    Selected on a TIPS Project
    by Ministry of SMEs and Startups

    Tech incubator program for startups
    · Selects potential startups and supports collaborations with private investments and governmental R&D units, in order to encourage new business establishments by high-quality human resources

  • 12

    Registered “Platform technology patent”

  • 08

    Pre-series A funded (USD 3.5m)

  • 09

    PCT applied for platform technology

  • 11

    Awarded from the 2020 BioChallenge sponsored by Cytiva

    One of the largest bio-awards in Korea, hosted by KoreaBIO and sponsored by MoH/Cytiva
    · Selects promising Korean biotech with purpose to discover and support potential leaders of the emerging global bio industry

  • 02

    Series A funded (USD 12.5m)

  • 08

    Selected on a project by Korea Drug Development Fund (KDDF)

    Pan-governmental R&D project named as the ‘Fund for establishment of ecosystem for new drug R&D
    · Supports development and commercialization of new drug candidates, in order to enhance national competitiveness in new drug R&D sector

  • 03

    Series B funded (USD 33.5m)